Method and system for the diagnosis of inflammatory bowel disease (IBD)

EP4720684A1Pending Publication Date: 2026-04-08DIASORIN ITALIA SPA
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
EP · EP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2024-06-04
Publication Date
2026-04-08

Smart Images

  • Figure IB2024055430_12122024_PF_FP_ABST
    Figure IB2024055430_12122024_PF_FP_ABST
Patent Text Reader

Abstract

The invention relates to a method and kit for the diagnosis of Inflammatory Bowel Disease (IBD) in a subject. The diagnostic method is based on the detection of fecal Calprotectin and at least one further fecal biomarker selected from PGRP-S and MMP-8 in a stool sample from the subject. In a preferred embodiment, the fecal biomarkers concentration data obtained are analyzed and classified as affected by IBD or not affected by IBD by a supervised machine learning diagnosis model.
Need to check novelty before this filing date? Find Prior Art